Will the health pass and paid screening tests distort the monitoring of the epidemic?

THE CHEKING PROCESS – Every day, epidemiologists in France base their calculations on tests carried out spontaneously. From October 15, however, screening will become chargeable, except with a prescription. Will epidemic curves always be a valid indicator?

THE QUESTION. Since the entry into force of the health pass on August 9, screening centers have been taken by storm. The approximately 28% of French people who do not have a complete vaccination schedule only have this means to access restaurants, bars, museums, cinemas or to travel by train. Between August 9 and August 15, Public Health France thus noted an explosive average of 800,000 tests carried out each day, against only 300,000 beginnings in July. Isn’t this sudden influx likely to suddenly collapse when, on October 15, the tests will pay off? Should we then fear a shortage of epidemiological data, added to a number of false positive cases on the decline?

CHECKS. First of all, if the cost of the PCR or antigen test has not yet been fixed by the authorities, it certainly promises to be largely dissuasive. By mentioning it, Gabriel Attal was clear on the intentions of the executive: to push more French people towards vaccination, by limiting

This article is for subscribers only. You have 84% left to discover.

Pushing back the limits of science is also freedom.

Keep reading your article for € 1 for 2 months

Already subscribed? Log in


Leave a Reply

Your email address will not be published. Required fields are marked *